[go: up one dir, main page]

NO20040258L - Preparat for behandling av negleinfeksjoner med nitrogenoksid - Google Patents

Preparat for behandling av negleinfeksjoner med nitrogenoksid

Info

Publication number
NO20040258L
NO20040258L NO20040258A NO20040258A NO20040258L NO 20040258 L NO20040258 L NO 20040258L NO 20040258 A NO20040258 A NO 20040258A NO 20040258 A NO20040258 A NO 20040258A NO 20040258 L NO20040258 L NO 20040258L
Authority
NO
Norway
Prior art keywords
treatment
preparation
nitric oxide
nail infections
nail
Prior art date
Application number
NO20040258A
Other languages
English (en)
Inventor
Nigel Benjamin
Original Assignee
Univ Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Aberdeen filed Critical Univ Aberdeen
Publication of NO20040258L publication Critical patent/NO20040258L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
NO20040258A 2001-08-03 2004-01-20 Preparat for behandling av negleinfeksjoner med nitrogenoksid NO20040258L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0119011.5A GB0119011D0 (en) 2001-08-03 2001-08-03 Treatment of nail infections
PCT/GB2002/003575 WO2003013489A1 (en) 2001-08-03 2002-08-02 Treatment of nail infections with no

Publications (1)

Publication Number Publication Date
NO20040258L true NO20040258L (no) 2004-03-29

Family

ID=9919789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040258A NO20040258L (no) 2001-08-03 2004-01-20 Preparat for behandling av negleinfeksjoner med nitrogenoksid

Country Status (23)

Country Link
US (2) US20050037093A1 (no)
EP (1) EP1411908B1 (no)
JP (1) JP2005501069A (no)
KR (1) KR20040031780A (no)
CN (1) CN1321633C (no)
AT (1) ATE296094T1 (no)
AU (1) AU2002318001B2 (no)
BR (1) BR0211390A (no)
CA (1) CA2453243C (no)
DE (1) DE60204322T2 (no)
ES (1) ES2242042T3 (no)
GB (1) GB0119011D0 (no)
HR (1) HRP20040059B1 (no)
HU (1) HUP0401190A3 (no)
IL (2) IL159724A0 (no)
MX (1) MXPA04000670A (no)
NO (1) NO20040258L (no)
NZ (1) NZ530577A (no)
PL (1) PL213555B1 (no)
PT (1) PT1411908E (no)
RU (1) RU2298403C2 (no)
WO (1) WO2003013489A1 (no)
ZA (1) ZA200400491B (no)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
CA2537222A1 (en) 2003-07-09 2005-01-27 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
EP1871433B1 (en) 2005-03-24 2009-04-22 NOLabs AB Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor
WO2006125123A2 (en) * 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
JP5274248B2 (ja) 2005-05-27 2013-08-28 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 酸化窒素治療及び医生物的応用のための酸化窒素放出粒子
JP5165217B2 (ja) * 2006-07-07 2013-03-21 生化学工業株式会社 ゲル状又はフィルム状組成物並びにその製造方法及び用途
GB0618711D0 (en) * 2006-09-22 2006-11-01 Univ Exeter Agricultural treatment
WO2009055008A1 (en) * 2007-10-24 2009-04-30 Wharton Innovative Products, Llc Two part lotion for the delivery of nitrite ions to the skin
US9649334B2 (en) 2007-11-15 2017-05-16 The Uab Research Foundation Use of nitrite salts in chronic ischemia
EP2237788A4 (en) * 2007-12-27 2013-06-05 Aires Pharmaceuticals Inc COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
US20100098733A1 (en) * 2008-10-16 2010-04-22 Novan, Inc. Nitric oxide releasing particles for oral care applications
CA2740135A1 (en) * 2008-10-30 2010-05-06 Chris Miller Wound dressings comprising a nitric oxide gas producing component and an oxygen releasing component
ES2958410T3 (es) 2009-08-21 2024-02-08 Novan Inc Geles tópicos
DK2467173T3 (da) 2009-08-21 2019-07-29 Novan Inc Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf
BR112012008508A2 (pt) * 2009-10-13 2017-06-13 Novan Inc revestimento de sol-gel, substrato, método para produzir um revestimento de sol-gel
US10463689B2 (en) * 2009-10-14 2019-11-05 Board Of Supervisors Of Louisiana State University Pharmaceutical formulations of nitrite and uses thereof
EP2575829A4 (en) * 2010-06-07 2014-04-30 Topical Pharma Ab KIT FOR THE TREATMENT OF ONYCHOMYCOSIS BY STICKOXIDE
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118819A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
WO2012131412A2 (en) 2011-03-31 2012-10-04 Szabo Laszlo Gabor Pharmaceutical composition containing no, process for the preparation and use thereof
ES2804263T3 (es) 2011-07-05 2021-02-05 Novan Inc Composiciones tópicas
US9737362B2 (en) * 2011-07-06 2017-08-22 Boston Scientific Scimed, Inc. Tissue cutting systems and methods
KR20140053342A (ko) * 2011-08-17 2014-05-07 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 경구 전달 시스템을 통해 생리학적 및 치료학적 수준의 일산화질소를 생산하는 방법
CN104302175B (zh) 2012-03-14 2017-04-12 诺万公司 释放一氧化氮的药物组合物
CN105358160A (zh) 2013-02-20 2016-02-24 瑟阿瓦斯克公司 亚硝酸盐的药物制剂及其用途
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US12233289B2 (en) 2013-08-01 2025-02-25 Olaplex, Inc. Methods for fixing hair and skin
US9095518B2 (en) 2013-08-01 2015-08-04 Liqwd, Inc. Methods for fixing hair and skin
WO2016022170A1 (en) 2014-08-08 2016-02-11 Novan, Inc. Topical emulsions
AU2014305778B2 (en) 2013-08-08 2019-11-21 Ligand Pharmaceuticals Incorporated Topical compositions and methods of using the same
EP4249431A3 (en) * 2014-03-14 2023-11-29 SaNOtize Research and Development Corp. Compositions and methods for treating diseases or disorders using extended release nitric oxide releasing solutions
PT3142637T (pt) 2014-05-16 2020-10-15 Olaplex Inc Formulações e métodos de tratamento de queratina
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
JP6651499B2 (ja) 2014-07-11 2020-02-19 ノヴァン，インコーポレイテッド 局所用抗ウイルス薬組成物及びこれを使用する方法
US10925689B2 (en) 2014-07-14 2021-02-23 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
KR102661331B1 (ko) 2015-04-24 2024-04-30 올라플렉스, 인코포레이티드 릴렉싱된 헤어의 처리 방법
WO2017019614A1 (en) 2015-07-28 2017-02-02 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
JP7090549B2 (ja) 2016-03-02 2022-06-24 ノヴァン，インコーポレイテッド 炎症のための治療用組成物およびその治療方法
EP3442502A4 (en) 2016-04-13 2019-11-06 Novan, Inc. COMPOSITIONS, SYSTEMS, KITS AND METHODS FOR TREATING INFECTIONS
US9872821B1 (en) 2016-07-12 2018-01-23 Liqwd, Inc. Methods and formulations for curling hair
WO2018236803A1 (en) 2017-06-19 2018-12-27 Novan, Inc. Topical compositions and methods of using the same
EP3758679A4 (en) 2018-03-01 2021-12-15 Novan, Inc. NITROGEN OXIDE SUPPLIES AND METHOD OF USE THEREOF
US11472705B2 (en) 2018-03-13 2022-10-18 Sanotize Research And Development Corp. Nitric oxide releasing compositions
RU2704782C1 (ru) * 2018-10-09 2019-10-30 Елена Владимировна Герасимчук Способ криогенного лечения онихомикоза
GB2599818B (en) 2019-06-04 2024-01-31 Thirty Respiratory Ltd Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
BR112021023832A8 (pt) 2019-06-04 2023-02-28 Thirty Holdings Ltd Métodos e composições para geração de óxido nítrico e usos dos mesmos
US20240016831A1 (en) 2020-04-23 2024-01-18 Thirty Respiratory Limited Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2
EP4138794A1 (en) 2020-04-23 2023-03-01 Thirty Respiratory Limited Methods and compositions for treating and combatting tuberculosis
EP4125941A4 (en) * 2020-07-16 2024-04-10 SaNOtize Research and Development Corp. METHODS OF TREATING CONDITIONS SENSITIVE TO NITRIC OXIDE THERAPY
RU2769437C1 (ru) * 2021-07-08 2022-03-31 Светлана Николаевна Абрамова Способ восстановления роста ногтя

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY128187A (en) * 1993-06-23 2007-01-31 Icn Switzerland Ag Preparation for skin and mucous membrane
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
EP0746327B1 (en) 1994-02-21 2004-04-21 Aberdeen University Acidified nitrite as an antimicrobial agent
GB9804469D0 (en) * 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide

Also Published As

Publication number Publication date
EP1411908B1 (en) 2005-05-25
MXPA04000670A (es) 2004-10-27
HRP20040059A2 (en) 2004-08-31
HUP0401190A3 (en) 2008-08-28
BR0211390A (pt) 2004-08-17
GB0119011D0 (en) 2001-09-26
HUP0401190A2 (hu) 2004-11-29
AU2002318001B2 (en) 2007-02-15
DE60204322T2 (de) 2006-01-26
US20050037093A1 (en) 2005-02-17
WO2003013489A1 (en) 2003-02-20
HRP20040059B1 (en) 2008-05-31
CA2453243A1 (en) 2003-02-20
ES2242042T3 (es) 2005-11-01
CA2453243C (en) 2012-01-03
IL159724A0 (en) 2004-06-20
NZ530577A (en) 2007-01-26
JP2005501069A (ja) 2005-01-13
RU2298403C2 (ru) 2007-05-10
DE60204322D1 (de) 2005-06-30
IL159724A (en) 2006-04-10
PT1411908E (pt) 2005-08-31
PL366579A1 (en) 2005-02-07
ZA200400491B (en) 2005-04-22
CN1321633C (zh) 2007-06-20
US20100015253A1 (en) 2010-01-21
KR20040031780A (ko) 2004-04-13
EP1411908A1 (en) 2004-04-28
PL213555B1 (pl) 2013-03-29
RU2004101765A (ru) 2005-03-10
CN1564681A (zh) 2005-01-12
US9381381B2 (en) 2016-07-05
ATE296094T1 (de) 2005-06-15

Similar Documents

Publication Publication Date Title
NO20040258L (no) Preparat for behandling av negleinfeksjoner med nitrogenoksid
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
BR112012021337A8 (pt) formulações de apixaban.
WO2004062613A3 (en) Hiv integrase inhibitors
WO2005023185A3 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
MA32544B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
MY131964A (en) 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
BR122018009866B8 (pt) métodos para preparar compostos de éter aminocicloexílico e compostos intermediários
CY1115961T1 (el) Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
DE60316821D1 (de) Aminobenzothiazolverbindungen mit nos-hemmender wirkung
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
WO2018105941A3 (ko) 탈모방지 또는 발모촉진용 주사용 조성물
DE60213802D1 (de) Cak inhibitoren und deren verwendungen
WO2018106794A3 (en) Compositions and methods relating to molecular cerium-oxide nanoclusters
ATE363890T1 (de) Kationische polymerisate und deren verwendung in kosmetischen formulierungen
DE60325838D1 (de) Imidazoquinolinamine als adjuvantien für hiv dna vakzine
ATE420089T1 (de) Substituierte azachinazoline mit antiviraler wirkung
DK1537132T3 (da) Salt af mortin-6-glucuronid
MX2007011381A (es) Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion.
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
SE0300907D0 (sv) Novel compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application